• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Etanercept Product Approval Information - Licensing Action 5/27/99

Proper name: Etanercept
Tradename: Enbrel
Manufacturer: Immunex Corp, Seattle, WA, License #1132
Indication for Use: Polyarticular course juvenile rheumatoid arthritis
Approval Date: 5/27/99
Type of submission: Biologics license supplement


Approval Letter (PDF)

      Clinical - Part 2 (PDFs)
      Clinical Pharmacology and Biopharmaceutics (PDF)
      Statistical (PDF)